Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East

This open-label study investigated the safety and efficacy of tocilizumab in Middle Eastern patients with rheumatoid arthritis (RA). Patients whose Disease Activity Score based on 28 joints (DAS28) was >3.2 received tocilizumab 8 mg/kg intravenously every 4 weeks for 24 weeks. Patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammoudeh, Mohammed, Al Awadhi, Adel, Hasan, Eman Haji, Akhlaghi, Maassoumeh, Ahmadzadeh, Arman, Sadeghi Abdollahi, Bahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452319/
https://www.ncbi.nlm.nih.gov/pubmed/26089907
http://dx.doi.org/10.1155/2015/975028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452319/
https://www.ncbi.nlm.nih.gov/pubmed/26089907
http://dx.doi.org/10.1155/2015/975028

Ejemplares similares